. This review indicates the likely utilization of tucidinostat during the therapy of MM Sooner or later (Huang et al., 2019). Sun et al. uncovered that tucidinostat is efficient in MM treatment by way of regulating amounts of H3K27ac to enhance the transcription of succinate dehydrogenase subunit A ( Adenoid https://betteb322ozj5.dekaronwiki.com/user